Randall Severance

825 total citations
7 papers, 255 citations indexed

About

Randall Severance is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Randall Severance has authored 7 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 2 papers in Surgery and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Randall Severance's work include Cancer, Lipids, and Metabolism (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Randall Severance is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Randall Severance collaborates with scholars based in United States, Belgium and Italy. Randall Severance's co-authors include Helen M. Colhoun, Corinne Hanotin, Michel Farnier, Elisabeth Steinhagen‐Thiessen, Yunling Du, Stephen Donahue, Peter J.H. Jones, Maurizio Averna, Joel Neutel and Rizwana Mohseni and has published in prestigious journals such as Journal of Hepatology, Atherosclerosis and Human Vaccines & Immunotherapeutics.

In The Last Decade

Randall Severance

6 papers receiving 249 citations

Peers

Countries citing papers authored by Randall Severance

Since Specialization

Citations

This map shows the geographic impact of Randall Severance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Severance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Severance more than expected).

Fields of papers citing papers by Randall Severance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall Severance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Severance. The network helps show where Randall Severance may publish in the future.

Co-authorship network of co-authors of Randall Severance

This figure shows the co-authorship network connecting the top 25 collaborators of Randall Severance. A scholar is included among the top collaborators of Randall Severance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall Severance. Randall Severance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU) 2021 ·Human Vaccines & Immunotherapeutics ·Randall Severance, Howard Schwartz, Ron Dagan, (unknown), Jianing Li, Alison Pedley, Jonathan Hartzel, Tina M. Sterling, Katrina M. Nolan, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald, (unknown)	16
2	VK2809, a novel liver-directed thyroid receptor agonist, produces durable reductions in liver fat in patients with non-alcoholic fatty liver disease: results of 4-week follow-up assessment from a 12-week phase 2 randomized, placebo-controlled trial 2020 ·Journal of Hepatology ·(unknown), Rohit Loomba, Joel Neutel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Randall Severance, Rizwana Mohseni, David Bernard, (unknown)	7
3	LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial 2019 ·Journal of Hepatology ·Rohit Loomba, Joel Neutel, Rizwana Mohseni, David W. Bernard, Randall Severance, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroko Masamune, (unknown)	50
4	Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study 2018 ·Human Vaccines & Immunotherapeutics ·Remon Abu‐Elyazeed, William Jennings, Randall Severance, Michael J. Noss, Adrian Caplanusi, Michael Povey, Ouzama Henry	11
5	Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial 2015 ·Atherosclerosis ·Michel Farnier, Peter J.H. Jones, Randall Severance, Maurizio Averna, Elisabeth Steinhagen‐Thiessen, Helen M. Colhoun, Yunling Du, Corinne Hanotin, Stephen Donahue	160
6	Efficacy and Safety of Combining Alirocumab With Atorvastatin or Rosuvastatin versus Statin Intensification or Adding Ezetimibe in High Cardiovascular Risk Patients: ODYSSEY OPTIONS I and II 2014 ·Kölner Universitäts PublikationsServer (Universität zu Köln) ·Harold Bays, Michel Farnier, Daniel Gaudet, Robert Weiss, (unknown), Gerald F. Watts, Ioanna Gouni‐Berthold, Jennifer G. Robinson, Peter H. Jones, Randall Severance, Maurizio Averna, Elisabeth Steinhagen‐Thiessen, Helen M. Colhoun, Jian Zhao, Yunling Du, Corinne Hanotin, Stephen Donahue	11
7	ETC-1002 Lowers LDL-Cholesterol and Beneficially Modulates Other Cardio-Metabolic Risk Factors in Hypercholesterolemic Subjects† 2013 ·Journal of clinical lipidology ·(unknown), Diane MacDougall, Jeffrey C. Hanselman, Mark A. Milad, Scott McBride, Lorenzo A. DiCarlo, Roger S. Newton, Christie M. Ballantyne, Michael Davidson, Randall Severance, James M. McKenney, James T. VanderLugt, Harold Bays, John Rubino, Stephen W. Halpern, Linda Gaudiani, Michael J. Koren, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact